These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 7923168

  • 1. Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumor response.
    McMahon KS, Wieman TJ, Moore PH, Fingar VH.
    Cancer Res; 1994 Oct 15; 54(20):5374-9. PubMed ID: 7923168
    [Abstract] [Full Text] [Related]

  • 2. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion.
    Fingar VH, Wieman TJ, Wiehle SA, Cerrito PB.
    Cancer Res; 1992 Sep 15; 52(18):4914-21. PubMed ID: 1387584
    [Abstract] [Full Text] [Related]

  • 3. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.
    Taber SW, Fingar VH, Coots CT, Wieman TJ.
    Clin Cancer Res; 1998 Nov 15; 4(11):2741-6. PubMed ID: 9829737
    [Abstract] [Full Text] [Related]

  • 4. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
    Wong Kee Song LM, Wang KK, Zinsmeister AR.
    Cancer; 1998 Jan 15; 82(2):421-7. PubMed ID: 9445202
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
    Chan AL, Juarez M, Allen R, Volz W, Albertson T.
    Photodermatol Photoimmunol Photomed; 2005 Apr 15; 21(2):72-8. PubMed ID: 15752124
    [Abstract] [Full Text] [Related]

  • 6. A comparison of the effects of photodynamic therapy on normal and tumor blood vessels in the rat microcirculation.
    Reed MW, Wieman TJ, Schuschke DA, Tseng MT, Miller FN.
    Radiat Res; 1989 Sep 15; 119(3):542-52. PubMed ID: 2772144
    [Abstract] [Full Text] [Related]

  • 7. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model.
    Ferrario A, Kessel D, Gomer CJ.
    Cancer Res; 1992 May 15; 52(10):2890-3. PubMed ID: 1581904
    [Abstract] [Full Text] [Related]

  • 8. The effects of serum on cellular uptake and phototoxicity of mono-L-aspartyl chlorin e6 (NPe6) in vitro.
    Sheyhedin I, Aizawa K, Araake M, Kumasaka H, Okunaka T, Kato H.
    Photochem Photobiol; 1998 Jul 15; 68(1):110-4. PubMed ID: 9679456
    [Abstract] [Full Text] [Related]

  • 9. Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).
    Mori K, Yoneya S, Ohta M, Sano A, Anzai K, Peyman GA, Moshfeghi DM.
    Ophthalmology; 1999 Jul 15; 106(7):1384-91. PubMed ID: 10406627
    [Abstract] [Full Text] [Related]

  • 10. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model.
    Gomer CJ, Ferrario A.
    Cancer Res; 1990 Jul 01; 50(13):3985-90. PubMed ID: 2354446
    [Abstract] [Full Text] [Related]

  • 11. Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study.
    Kikuchi T, Asakura T, Aihara H, Shiraki M, Takagi S, Kinouchi Y, Aizawa K, Shimosegawa T.
    Anticancer Res; 2003 Jul 01; 23(6C):4897-900. PubMed ID: 14981942
    [Abstract] [Full Text] [Related]

  • 12. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse.
    Kobayashi W, Liu Q, Nakagawa H, Sakaki H, Teh B, Matsumiya T, Yoshida H, Imaizumi T, Satoh K, Kimura H.
    Oral Oncol; 2006 Jan 01; 42(1):46-50. PubMed ID: 16266818
    [Abstract] [Full Text] [Related]

  • 13. Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries.
    Nagae T, Aizawa K, Uchimura N, Tani D, Abe M, Fujishima K, Wilson SE, Ishimaru S.
    Lasers Surg Med; 2001 Jan 01; 28(4):381-8. PubMed ID: 11344521
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effects of photodynamic therapy using differently substituted zinc phthalocyanines on vessel constriction, vessel leakage and tumor response.
    Fingar VH, Wieman TJ, Karavolos PS, Doak KW, Ouellet R, van Lier JE.
    Photochem Photobiol; 1993 Aug 01; 58(2):251-8. PubMed ID: 8415918
    [Abstract] [Full Text] [Related]

  • 16. Threshold power levels for NPe6 photodynamic therapy.
    Kazi AA, Peyman GA, Unal M, Khoobehi B, Yoneya S, Mori K, Moshfeghi D, Moshfeghi AA.
    Ophthalmic Surg Lasers; 2000 Aug 01; 31(2):136-42. PubMed ID: 10743925
    [Abstract] [Full Text] [Related]

  • 17. Photodynamic therapy with a diode laser for implanted fibrosarcoma in mice employing mono-L-aspartyl chlorin E6.
    Katsumi TA, Aizawa K, Kuroiwa Y, Saito K, Kurata Y, Ii Y, Okunaka T, Konaka C, Kato H.
    Photochem Photobiol; 1996 Oct 01; 64(4):671-5. PubMed ID: 8863472
    [Abstract] [Full Text] [Related]

  • 18. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
    Chan WS, Brasseur N, La Madeleine C, van Lier JE.
    Anticancer Res; 1996 Oct 01; 16(4A):1887-92. PubMed ID: 8712717
    [Abstract] [Full Text] [Related]

  • 19. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
    Seshadri M, Spernyak JA, Mazurchuk R, Camacho SH, Oseroff AR, Cheney RT, Bellnier DA.
    Clin Cancer Res; 2005 Jun 01; 11(11):4241-50. PubMed ID: 15930363
    [Abstract] [Full Text] [Related]

  • 20. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
    Ohtani K, Usuda J, Ichinose S, Ishizumi T, Hirata T, Inoue T, Maehara S, Imai K, Kubota M, Tsunoda Y, Yamada M, Tsutsui H, Yamada K, Kuroiwa Y, Furukawa K, Okunaka T, Kato H.
    Int J Oncol; 2008 Feb 01; 32(2):397-403. PubMed ID: 18202762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.